chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A report was received from a health care professional on 11/07/02, concerning a 2 year old female vaccinee who inadvertently received 0.5ml of Fluvirin on 11/06/02. There was insufficient information to determine the reporter's causality assesment.
Lightheaded, chest pain, cough, headache, fever 101 degrees for 2 days.
On 12/11/2022 Pediatric 5-year-old Patient was accompanied to the COVID-19 vaccination site by his father for his first dose in the Moderna 6months-5years old primary series (LOT#AS1412B). Patient was vaccinated by CMA who provided this following written report to Charge Nurse, RN to complete this VAERS.  Per CMA?s written report:  ?Patient pulled his arm away as the needle entered his Left arm deltoid which caused the syringe needle to withdraw prematurely out of the patient?s arm before any dose was administered. No vaccine was administered by this CMA. Vanish point needle remained intact. Full vaccine dose still observed in the contaminated vaccination syringe which I gave to the Charge Nurse, RN who I alerted for assistance, and the Charge Nurse safely disposed of the contaminated syringe and noted vaccine wastage. Charge Nurse, RN then notified Site Supervisor, RN who intervened and spoke to the child?s father with me. Parent consented to a second attempt at vaccination. Parent requested that they wanted the second attempted vaccination in the same left arm. Site Supervisor, RN aware of parent request and described risks to parent, and the parent acknowledged yet still wanted in same left arm. Child vaccinated in left arm at 1312 (1:12pm). No patient concerns noted during post-vaccination period. Patient ambulated safely out of the clinic with parent.?
I have had three doses of Pfizer Covid vaccine. Every single time, 2-3 weeks after the dose, I experienced runs of PVC?s.  I got three doses: dec 14, January 14 and July 30
Moderna COVID-19 vaccine administered after temperature excursion; Moderna COVID-19 vaccine administered after temperature excursion; Moderna COVID-19 vaccine administered after temperature excursion; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Sep-2021. The most recent information was received on 13-Sep-2021 and was forwarded to Moderna on 14-Sep-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered after temperature excursion), PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine administered after temperature excursion) and EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine administered after temperature excursion) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C1A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jul-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered after temperature excursion) and PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine administered after temperature excursion). On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine administered after temperature excursion). On 20-Jul-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered after temperature excursion) and PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine administered after temperature excursion) had resolved. At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine administered after temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter stated that they went by the acceptable limits of Janssen Temperature Excursion, as they forgot they had one vial of the Moderna (10-dose vial) with Lot number-026C1A.  The reporter stated that maximum or minimum temperatures reached are as follows 08-July- greater than 12.23 C max-37 minutes 11-July-greater than 9.42 C max-33 minutes 11-July-2021- 11:26- 9.06°C max-32 minutes 11-July-2021- 21:28- 9.42°C max- 1 hour 5 min. 12-July- 10.6 C max- 51 minutes.  The reporter stated that the excursion duration greater than 8 degree C (46 degree F)-3 hours and 38 minutes at the absolute most and all at different times.  No concomitant product use was provided by the reporter.   No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 13-Sep-2021: ADR Received on 13 Sep 2021,contain Patient Information (Initial, Gender,Age,Race and Ethinicity)
Seizure lasting 1-5minutes.  Fever 104+.  Final Diagnosis:  Febrile Convulsions. Additional: Acute Suppurative OM w/o ruptured eardrum.  Treatments: TYLENOL & AMOXICILLIN.
Within a few hours, I developed a debilitating headache in the temples and back of my head.  After eating at 5pm, I got a very sore stomach.  Within an hour of that I developed a fever and chills that lasted about 24 hours.  From evening through the next morning, I urinated almost every hour.  My joints started aching worse than normal that night and last for three days.  My headache has yet to go away.  I am still experiencing fatigue.
shoulder/arm pain during 1st week. bruise and rash occurred after injection next day. bruise and rash comes and goes-same spot as injection site. shoulder pain constant.
Employee received first vaccine 12/22/21. Developed hives on neck and face later that day. Took Benadryl routinely and Prednisone 10mg daily for three days with resolution of symptoms. Patient has a history of hives after flu vaccine, antibiotics, and childhood vaccines. Had second COVID vaccine 1/12/21. Developed hives on neck, arms, chest, and back. Also had a mild headache and nausea on 1/12/21 which have resolved. Is again taking Prednisone and Benadryl. Patient did not seek medical help. She has Prednisone on hand for these reactions since they are common for her.
Received MMR 10/06/06 on 11/17/06 developed swollen lymph nodes in neck, 11/20 rash on trunk, 11/22 joint pain, stiffness, 11/26 fine and asymptomatic.
Myalgic encephalitis sufferers anecdotally experienced a reduction in symptoms after receiving an mRNA vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Myalgic encephalitis sufferers anecdotally experienced a reduction in symptoms after receiving an mRNA vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Myalgic encephalitis sufferers anecdotally experienced a reduction in symptoms after receiving an mRNA vaccine). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Myalgic encephalitis sufferers anecdotally experienced a reduction in symptoms after receiving an mRNA vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was not provided by the reporter.
Severe headache and neckache. Nausea, vomiting,  diarrhea. Profound fatigue. Facial flushing. Injection site: red, hot indurated, 12 centimeters in diameter.  Inability to focus, poor concentration, lack of mental clarity,  and memory problems.
I had severe body rigors/Chills; I threw up; I had a 101.8 fever; I was pretty much out all day yesterday, like I was out sleeping with a fever; pretty much out; This is a spontaneous report from a contactable Nurse. A 59-year-old female patient started to receive first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number: EJ1685, Expiry Date: 31Mar2021) intramuscular on 19Dec2020 at 0.3 mL, single for covid-19 immunization from her work. Patient history was reported as no. The patient didn't have really anything. Concomitant medication included paracetamol (TYLENOL), the patient had been taking some Tylenol. The patient had a vaccination Saturday morning on 19Dec2020 and had a very bad reaction during the night. The patient had severe body rigors and chills. She threw up. She had a 101.8 fever. She was pretty much out all day yesterday, like was out sleeping with a fever. Investigation assessment was no. The patient just would like to know if she can get the second injection. Outcome of the events was unknown. The events were considered as related by the reporter via global introspection (Method of assessment).
Patient experienced wheezing, dizziness, redness, itching, anaphylacyic-type reaction.  Patient was given 0.3mg epinephrine and brought to ED.  In ED, given acetaminophen, diphenhydramine, famotidine, lorazpeam.  Patient stable and released home on 1/17/2021.
Back Ache; Nodule on Injection Site (Egg Size); Chills; fever; This spontaneous case was reported by a nurse and describes the occurrence of BACK PAIN (Back Ache), VACCINATION SITE NODULE (Nodule on Injection Site (Egg Size)), CHILLS (Chills) and PYREXIA (fever) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced BACK PAIN (Back Ache), VACCINATION SITE NODULE (Nodule on Injection Site (Egg Size)), CHILLS (Chills) and PYREXIA (fever). In February 2021, BACK PAIN (Back Ache), VACCINATION SITE NODULE (Nodule on Injection Site (Egg Size)), CHILLS (Chills) and PYREXIA (fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   ? No treatment information was provided. ?The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable
Presented on 1/31/14 local injection reaction: including - soreness, warmth, swelling, erythema and induration. No fever at this time. Injection site appears to have mild cellulitis, referred to primary care physician.
FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. The patient experienced inadvertently administered expired FLUMIST QUADRIVALEN to three patients. The outcome of the event of inadvertently administered expired FLUMIST QUADRIVALENT to three patients is unknown. The report was considered to be non-serious.
12 weeks of horrible pain from the 2 doses; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN (12 weeks of horrible pain from the 2 doses) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Psoriasis and Psoriatic arthritis.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, the patient experienced PAIN (12 weeks of horrible pain from the 2 doses). At the time of the report, PAIN (12 weeks of horrible pain from the 2 doses) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.  This is a spontaneous case concerning a 56-year-old patient of an unknown gender with relevant concurrent medical conditions of Psoriasis and Psoriatic arthritis, who experienced non serious unexpected event of Pain. The event occurred on an unknown date after the second dose of mRNA-1273 vaccine. Concurrent medical conditions of Psoriasis and Psoriatic arthritis remain confounders. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2021-395930 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a 56-year-old patient of an unknown gender with relevant concurrent medical conditions of Psoriasis and Psoriatic arthritis, who experienced non serious unexpected event of Pain. The event occurred on an unknown date after the second dose of mRNA-1273 vaccine. Concurrent medical conditions of Psoriasis and Psoriatic arthritis remain confounders. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Client received AstraZeneca COVID vaccine, no reaction. AstraZeneca COVID vaccine unavailable. Janssen given as an alternative on 09/15/21.
On 10/9/01, right arm was painful, with swelling at the injection site and developed a temperature of 102F. On 10/10/01, swelling extended to right elbow and right shoulder and was still very red and painful. She was dizzy, could not focus and needed assistance walking. She was trembling and had profuse perspiring. On 10/11/01, swelling had slightly subsided and redness had lessened. She saw an MD.
Myalgia, NauseaVomiting, CHILLS, SORE THROAT, WEAKNESS Narrative:
Couldn't raise right arm above shoulder for 2 weeks. Dr. said it would go away. Very painful I can now raise my arm. But still painful and can get stiff also my right side neck and side. I use hot shower now-A.M. and a vibrator on my shoulder P.M. at first-I had nausea, hives, join pain.
pt recvd vax 15AUG95 & 24AGU95 pt devel a chicken pox rash;there questionable exposure prior to vax;pt's sister devel fever & chicken pox type rash (WAES95081590);No further details were provided;
This case involves an unknown age and gender patient who experienced feeling bad (feeling abnormal) for days after receiving INFLUENZA VACCINE. It was unknown if the patient had any medical history, concomitant disease or risk factor. Past medical treatment(s), vaccination(s) concomitant medication and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date were not reported) via unknown route in unknown administration site for prophylactic vaccination. On an unknown date the patient developed a non-serious made me feel bad for days (feeling abnormal) (unknown latency) following the administration of INFLUENZA VACCINE. It was reported "I am undecided whether I get my flu shot first or the booster". It was unknown if the patient experienced any additional symptoms/events. It was unknown if there were lab data/results available. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was unknown for the event. There will be no information available on the batch number for this case.
stiffness/ all over body stiffness; muscle pain; Son and friend had muffled ear/felt like there was water in ear but it was better within 24 hours; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious), outcome "unknown", described as "stiffness/ all over body stiffness"; MYALGIA (non-serious), outcome "unknown", described as "muscle pain"; EAR DISORDER (non-serious), outcome "recovered", described as "Son and friend had muffled ear/felt like there was water in ear but it was better within 24 hours".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201282842 same reporter, different dose and different event;
Very sleepy, could not stay awake; Headache; Nauseous; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 24Feb2021 at 15:00 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included aneurysm aortic (enlarged aorta), Chronic lymphocytic leukemia (CLL), eosinophilic esophagitis (EOE) and reduced 50 % kidney function. The patient was allergic to dairy. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metoprolol succinate (MANUFACTURER UNKNOWN) and pantoprazole (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Feb2021 at 12:00 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. On 25Feb2021 at 17:30, the patient experienced very sleepy and could not stay awake, headache and nauseous. The patient went to bed slept for 14 hours and awake feeling fine. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event very sleepy and could not stay awake, headache and nauseous were resolved on an unknown date in Feb2021.  No follow-up attempts are needed. No further information is expected.
About 10 minutes after the shot, patient stated her arm was numb and kind of tingling. She reported no other symptoms.
Chills, fever and tremors began around 2100 on night of vaccination, was reported symptoms subsided the following day. Found early morning of 2/22/2021 deceased in bed by live-in caregiver
Patient received dose #1 of Moderna on 3/23. He began to develop blistering rash on 4/21 but proceeded with dose #2 of Moderna on 4/23. He had acutely worsening blistering rash over the entire body and has continued to have new blisters up through today. Based on exam, I have diagnosed bullous pemphigoid and started him on prednisone. Referral was placed to Dermatology as well.
Onset of high fever to 103 degrees, generalized myalgias and nonproductive cough beginning 9/17/04.  Was evaluated on 9/20/04 with dx of viral illness.  Seen in f/u the next day and had more coughing.  Was prescribed Zithromycin.  Later that day, the pt questioned the possibility of this illness being associated with the MMR injection.
adverse reaction; This case was reported by a consumer via call center representative and described the occurrence of adverse reaction in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced adverse reaction. Shingrix was discontinued. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to Shingrix.  Additional details were reported as follows: This case was reported by the wife who reported for her husband. The patient had an adverse reaction to Shingrix and his doctor recommended he not get the second immunization. The reporter wanted to know what does your research show about the effectiveness of 1 of the 2 recommended does.
After receiving the vaccine, I caught COVID-19. I had headache body ache, sinus, fever, sore throat and coughing. I went to doctor and got the COVID-19 pill and my symptoms were cut in half and was able to return to work in 6 days.
8/21/2019 Pain around the injection site that remained a minor ailment until around 8:30 PM 8/24/2019 the shoulder of the left side of my body became very sore to a point that the use of ice pack or heat were not helping. The soreness spread up the neck and the pain lasted for hours. I took 800mg of IBuprofen @ 9:00 PM and the pain subsided enough to sleep around 11:00 PM. The following morning the pain in the left should and neck was still there but also spread into the right shoulder. The pain level was at a minor degree but noticeable and lasting all day. In the evening the pain worsened and I again took 800 mg IBuprofen. After 1 hour the pain lessened enough to sleep. This continues for the next few days until 8/28/2019. The skin on the left shoulder starts to become very sensitive to touch and temperature. It has a windburn feeling that started at top of the left arm and goes into the neck and shoulder blades. No ointment, cream, or topical pain killer work in lessening this feeling. No over the counter pain killer has helped either. Shoulders, shoulder blades and neck pain are also still present.
What I can remember is that experienced  an aching sensation to my low back, also had body aches and headaches in the afternoon of my first dose Moderna vaccine. I do not remember which arm I received my vaccine. These symptoms have resolved now.
Woke up with chest pains and BPM was over 160. Mother took him to the ER where he was tested and observed for about 4 hours. Went and saw PCP, then was referred to a Cardiologist. Seeing Cardiology doctor at the end of this month.
Information has been received from a consumer concerning her daughter who was vaccinated with a 0.5 mL first dose of Gardasil (lot # not reported). The consumer reported that her daughter fainted after receiving Gardasil. Additional information has been requested.
89 yo F with PMH of CAD s/p PCI to LAD in 2021, HFpEF, HTN, HLD and COPD presented to Medical Center for gerenally not feeling well for the last several days. Was found to be hypoxic to 86% by EMS. In the ED also c/o retrosternal chest pain/hevyness. After returning from CTA rapid response was called for hypotension and new onset Afib. Patiten given IVF and started on levophed and amiodarone gtt. Given continued complaints of 8/10 retrosternal chest pain patient was also started on Nitro gtt. She was given ASA 325 and plavix 75mg. Recieved one dose of weight based lovenox in the ED and also started on heparin gtt. Converted to sinus rhythm around 430am. Troponin 3.05-- >10.41-- >15. Continues to complain of chest pain. Last ischemic eval was in 2018 and was reportedly normal although no records are available for review. Also found to be COVID positive
Every time I have gotten the Pfizer vaccine, it starts my period or causes spotting (menstrual bleeding).
A report was received from a health care professional on 27 October 2003 concerning a 72 year old male vaccine who received a dose of Fluvirin vaccine on 13 October 2003 and inadvertently received a second dose on 27 October 2003. On 13 October 2003, the vaccine was administered Fluvirin and he inadvertently received a second dose of Fluvirin and he inadvertently received a second dose of fluvirin two weeks later on 27 October 2003.  No adverse events were reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 01 December 2003: Follow up information was received from a health care professional on 01 December 2003 indicating the vaccine was 65 years old. No follow up pending.